Chemed Cash Flow Statement
NYSE: CHEHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Chemed free cash flow
In fiscal 2025, Chemed generated $388.3 million of operating cash flow and spent $62.8 million on capital expenditures. That left free cash flow of $325.5 million, a free-cash-flow margin of 12.9% of revenue. Free cash flow was down 11.5% from the prior year's $368.0 million.
Chemed returned $463.2 million to shareholders: $31.7 million in dividends and $431.5 million in share repurchases, equal to 142% of free cash flow. Free cash flow covered dividend payments 10.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Chemed cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 265.24M | 302.00M | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M |
| Net Income growth (YoY) | -12.17% | +10.82% | +9.17% | -7.05% | -15.94% | +45.26% | +7.00% | +109.36% | -9.72% | -1.39% |
| Depreciation & Amortization | 64.84M | 63.05M | 60.87M | 59.17M | 59.05M | 56.58M | 45.20M | 38.86M | 35.63M | 34.64M |
| Stock-Based Compensation | 38.68M | 52.11M | 40.79M | 33.61M | 31.42M | 26.80M | 21.34M | 19.23M | 16.26M | 13.77M |
| Change in Working Capital | 31.12M | 2.39M | -49.72M | -36.36M | 156.00K | 32.73M | 7.80M | 921.00K | 14.61M | -38.81M |
| Operating Cash Flow | 388.27M | 417.50M | 330.30M | 309.89M | 308.60M | 489.29M | 301.25M | 287.14M | 162.50M | 135.39M |
| Capital Expenditures | -62.80M | -49.53M | -56.85M | -57.33M | -58.67M | -58.83M | -53.02M | -52.87M | -64.30M | -39.77M |
| Investing Cash Flow | -59.34M | -143.91M | -60.64M | -59.40M | -57.76M | -61.56M | -190.76M | -105.22M | -67.61M | -39.86M |
| Dividends Paid | -31.70M | -27.09M | -23.50M | -22.02M | -22.02M | -21.08M | -19.79M | -18.66M | -17.37M | -16.44M |
| Share Repurchases | -431.50M | -361.39M | -67.70M | -114.52M | -576.04M | -175.59M | -92.63M | -158.88M | -94.64M | -102.31M |
| Financing Cash Flow | -432.77M | -359.19M | -79.83M | -209.25M | -380.62M | -271.21M | -109.16M | -188.20M | -99.08M | -94.95M |
| Net Change in Cash | -103.83M | -85.61M | 189.83M | 41.23M | -129.78M | 156.52M | 1.33M | -6.29M | -4.19M | 583.00K |
| Free Cash Flow | 325.48M | 367.97M | 273.44M | 252.56M | 249.92M | 430.46M | 248.23M | 234.27M | 98.19M | 95.62M |
This table shows 10 annual periods of Chemed's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CHE's reporting calendar. What is a cash flow statement?